North America point of care diagnostics Market Share Analysis Report, 2023-2032
The North America point of care diagnostics market size accounted for USD 17.95 billion in 2022 and is estimated to achieve a market size of USD 34.98 billion by 2032, growing at a CAGR of 6.9% from 2023 to 2032.
Key Pointers:
Report Scope of the North America point of care diagnostics Market
|
Report Coverage |
Details |
|
Market Size in 2023 |
USD 19.19 Billion |
|
Market Size by 2032 |
USD 34.98 Billion |
|
Growth Rate from 2023 to 2032 |
CAGR of 6.9% |
|
Base Year |
2022 |
|
Forecast Period |
2023 to 2032 |
|
Segments Covered |
Product, End-use, Type |
Point-of-care (POC) diagnosis refers to performing diagnostic tests at the site of the patient. The growing geriatric population and the ability of POC diagnostic tests to deliver immediate results are likely to fuel the demand for POC diagnostic tests. Furthermore, a rise in funding from the government & private institutions is a key factor driving the market’s growth. An increase in the adoption of mobile diagnostic devices in the region is also one of the key factors driving demand for POC testing.
The growth can be attributed to the rise in the geriatric population and the ability of point-of-care (POC) diagnostic tests to deliver immediate results. Furthermore, a rise in funding from the government & private institutions is a key factor driving the industry’s growth. An increase in the adoption of mobile diagnostic devices in the region is also one of the key factors driving demand for POC testing.
An increase in funding from multiple sources, including the U.S. department of defense (DOD), NIH, and private foundations such as the Bill & Melinda Gates Foundation, is expected to drive the market’s growth. For instance, Grand Challenges Canada and the Bill & Melinda Gates Foundation have launched a joint initiative for POC diagnostics. These organizations are involved in the development and integration of different diagnostic components into interoperable POC platforms with “plug-and-play” characteristic features and the capability of running diverse tests from various developers. Research is conducted to incorporate each test on a common platform with a single interface, enabling analysis of different sample specimens using various approaches for analysis.
Such institutions are involved in funding various projects for the development of POC diagnostics to different organizations including California Institute of Technology, Dartmouth College, and Seventh Sense Biosystems. Moreover, NIH, through the Point-of-Care Technologies Research Network, has been funding the development of these technologies for screening infectious diseases & cancer as well as for primary care. In August 2022, Nanopath, Inc. received funding of USD 10 million from Medtech Convergence Fund and Norwest Venture Partners with participation from Green D Ventures and Gingerbread Capital. The funding would help develop POC diagnostics for women’s health.
Key players operating in the market are focusing on collaboration for the development of new products. For instance, in December 2021, QIAGEN and Denovo Biopharma LLC announced a partnership to establish a blood-based companion diagnostic test. Moreover, the companies are also emphasizing on launching of innovative technologies to increase the efficiency of diagnostic testing. For instance, in 2021, F. Hoffmann-La Roche Ltd launched a new blood glucose meter Accu-Chek Instant system, which helped the company expand its personalized diabetes management business.
Some of the prominent players in the North America point of care diagnostics Market include:
Segments Covered in the Report
This report forecasts the volume and revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor has segmented the North America point of care diagnostics market.
By Product
By End-use
By Type
By Country
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Definitions
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 Nova one advisor’s Internal Database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.5.5 Details Of Primary Research
1.6 Information Or Data Analysis
1.6.1 Market Categorization
1.6.2 Point - Of - Care Testing
1.6.2.1 Poc - End - Use Penetration Mapping
1.6.3 Data Analysis Models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.8.1.1 Approach 1: Commodity Flow Approach
1.8.1.2 Approach 2: Country - Wise Market Estimation Using The Bottom - Up Approach
1.9 North America Market: Cagr Calculation
1.10 List Of Secondary Sources
1.11 List Of Primary Sources
1.12 Objectives
1.12.1 Objective 1:
1.12.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Market Summary
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.1.3 Molecular Technology Intervention
3.1.3.1 Key Factors Considered For Analyzing Molecular Technology Interventions Across Point-Of-care (Poc) Testing
3.2 Penetration And Growth Prospect Mapping For Poc Products, 2022
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Introduction Of Clia - Waived Tests
3.3.1.2 Rise In Funding From Government And Private Institutions
3.3.1.3 Growing Geriatric Population
3.3.1.4 Growing Prevalence Of Targeted Diseases
3.3.1.5 Growing Demand For Home Healthcare And Introduction Of Advanced Technology - Enabled Products
3.3.2 Market Restraint Analysis
3.3.2.1 Presence Of Ambiguous Regulatory Framework
3.3.3 Market Challenge Analysis
3.3.3.1 Poc Devices Pose Challenges In Maintaining Quality Standards
3.3.4 Market Opportunity Analysis
3.3.4.1 Networking & Remote Access Integration Of Poc Diagnostics Products
3.3.4.1.1 Smartphone Orientation
3.3.4.1.2 Embedded Vision - Based Solutions
3.3.4.1.3 Digital Technologies
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s
3.6 Market Entry Strategies
3.7 Price - Cost - Margin Analysis For Poc Testing
3.8 User Perspective Analysis
3.8.1 Consumer Behavior Analysis
3.9 Technology Overview
3.10 Poc Diagnostics: Market Influencers
3.10.1 High Sensitivity
3.10.2 Shift To Molecular Diagnostics
3.10.3 Glucose Testing
3.10.4 Hba1c Testing
3.10.5 Coagulation Testing
3.10.6 Fertility Testing
3.10.7 Infectious Disease
3.10.8 Cardiac Markers
3.10.9 Thyroid - Stimulating Hormone
3.10.10 Hematology
3.10.11 Primary Care Systems
3.10.12 Decentralized Clinical Chemistry
3.10.13 Feces
3.10.14 Lipid Testing
3.10.15 Cancer Marker
3.10.16 Blood Gas/Electrolytes
3.10.17 Ambulatory Chemistry
3.10.18 Drug Of Abuse (Doa) Testing
3.10.19 Urinalysis
3.11 Covid - 19 Impact Analysis
3.12 Overview
3.12.1 Covid - 19 Point - Of - Care Diagnostics: Technology Overview
3.12.2 Covid - 19 Point - Of - Care Diagnostics: Regulatory Overview
3.12.3 Covid - 19 Point - Of - Care Diagnostics: Competitive Landscape
Chapter 4 Product Business Analysis
4.1 North America Point - Of - Care (Poc) Diagnostics Market: Product Movement Analysis
4.2 Glucose Testing
4.2.1 Glucose Testing Market Estimates And Forecast, 2020 - 2032
4.2.2 Glucose Testing Market, By End - Use
4.2.2.1 Glucose Testing Market, By Hospital
4.2.2.2 Glucose Testing Market, By Laboratories
4.2.2.3 Glucose Testing Market, By Home Care
4.2.2.4 Glucose Testing Market, By Clinic
4.2.2.5 Glucose Testing Market, By Physician Office
4.2.2.6 Glucose Testing Market, By Pharmacy & Retail Clinics
4.2.2.7 Glucose Testing Market, By Non - Practice Clinics
4.2.2.8 Glucose Testing Market, By Urgent Care Clinics
4.2.2.9 Glucose Testing Market, By Others
4.2.2.10 Glucose Testing Market, By Rural Health Clinic
4.2.2.11 Glucose Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.2.3 Glucose Testing Market, By Disease
4.2.3.1 Diabetes
4.2.3.2 Glucose Testing Market, By Diabetes
4.2.3.3 Others
4.2.3.4 Glucose Testing Market, By Others
4.3 Hba1c Testing
4.3.1 Hba1c Testing Market Estimates And Forecast, 2020 - 2032
4.3.2 Hba1c Testing Market, By End - Use
4.3.2.1 Hba1c Testing Market, By Hospital
4.3.2.2 Hba1c Testing Market, By Laboratories
4.3.2.3 Hba1c Testing Market, By Home Care
4.3.2.4 Hba1c Testing Market, By Clinic
4.3.2.5 Hba1c Testing Market, By Physician Office
4.3.2.6 Hba1c Testing Market, By Pharmacy & Retail Clinics
4.3.2.7 Hba1c Testing Market, By Non - Practice Clinics
4.3.2.8 Hba1c Testing Market, By Urgent Care Clinics
4.3.2.9 Hba1c Testing Market, By Others
4.3.2.10 Hba1c Testing Market, By Rural Health Clinic
4.3.2.11 Hba1c Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.3.3 Hba1c Testing Market, By Disease
4.3.3.1 Diabetes
4.3.3.2 Hba1c Testing Market, By Diabetes
4.3.3.3 Others
4.3.3.4 Hba1c Testing Market, By Others
4.4 Coagulation Testing
4.4.1 Coagulation Testing Market Estimates And Forecast, 2020 - 2032
4.4.2 Coagulation Testing Market, By End - Use
4.4.2.1 Coagulation Testing Market, By Hospital
4.4.2.2 Coagulation Testing Market, By Laboratories
4.4.2.3 Coagulation Testing Market, By Home Care
4.4.2.4 Coagulation Testing Market, By Clinic
4.4.2.5 Coagulation Testing Market, By Physician Office
4.4.2.6 Coagulation Testing Market, By Pharmacy & Retail Clinics
4.4.2.7 Coagulation Testing Market, By Non - Practice Clinics
4.4.2.8 Coagulation Testing Market, By Urgent Care Clinics
4.4.2.9 Coagulation Testing Market, By Others
4.4.2.10 Coagulation Testing Market, By Rural Health Clinic
4.4.2.11 Coagulation Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.4.3 Coagulation Testing Market, By Disease
4.4.3.1 Thrombosis
4.4.3.2 Coagulation Testing Market, By Thrombosis
4.4.3.3 Hemophilia
4.4.3.4 Coagulation Testing Market, By Hemophilia
4.4.3.5 Others
4.4.3.6 Coagulation Testing Market, By Others
4.5 Fertility/Pregnancy
4.5.1 Fertility/Pregnancy Market Estimates And Forecast, 2020 - 2032
4.5.2 Fertility Testing Market, By End - Use
4.5.2.1 Fertility Testing Market, By Hospital
4.5.2.2 Fertility Testing Market, By Laboratories
4.5.2.3 Fertility Testing Market, By Home Care
4.5.2.4 Fertility Testing Market, By Clinic
4.5.2.5 Fertility Testing Market, By Physician Office
4.5.2.6 Fertility Testing Market, By Pharmacy & Retail Clinics
4.5.2.7 Fertility Testing Market, By Non - Practice Clinics
4.5.2.8 Fertility Testing Market, By Urgent Care Clinics
4.5.2.9 Fertility Testing Market, By Others
4.5.2.10 Fertility Testing Market, By Rural Health Clinic
4.5.2.11 Fertility Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.5.3 Fertility Testing Market, By Type
4.5.3.1 Lh - Ovulation Elite Tes
4.5.3.2 Fertility Testing Market, By Lh - Ovulation Elite Test
4.5.3.3 Hcg - Pregnancy Tests
4.5.3.4 Fertility Testing Market, By Hcg - Pregnancy Tests
4.5.3.5 Fertility Tests
4.5.3.6 Fertility Testing Market, By Fertility Tests
4.5.3.7 Others
4.5.3.8 Fertility Testing Market, By Others
4.6 Infectious Disease Testing
4.6.1 Infectious Disease Testing Market Estimates And Forecast, 2020 - 2032
4.6.2 Infectious Disease Testing Market, By End - Use
4.6.2.1 Infectious Disease Testing Market, By Hospital
4.6.2.2 Infectious Disease Testing Market, By Laboratories
4.6.2.3 Infectious Disease Testing Market, By Home Care
4.6.2.4 Infectious Disease Testing Market, By Clinic
4.6.2.5 Infectious Disease Testing Market, By Physician Office
4.6.2.6 Infectious Disease Testing Market, By Pharmacy & Retail Clinics
4.6.2.7 Infectious Disease Testing Market, By Non - Practice Clinics
4.6.2.8 Infectious Disease Testing Market, By Urgent Care Clinics
4.6.2.9 Infectious Disease Testing Market, By Others
4.6.2.10 Infectious Disease Testing Market, By Rural Health Clinic
4.6.2.11 Infectious Disease Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.6.3 Infectious Disease Testing Market, By Disease
4.6.3.1 Hiv Poc
4.6.3.2 Infectious Disease Testing Market, By Hiv Poc
4.6.3.3 Clostridium Difficile Poc
4.6.3.4 Infectious Disease Testing Market, By Clostridium Difficile Poc
4.6.3.5 Hbv Poc
4.6.3.6 Infectious Disease Testing Market, By Hbv Poc
4.6.3.7 Pneumonia Or Streptococcus - Associated Infections
4.6.3.8 Infectious Disease Testing Market, By Pneumonia Or Streptococcus Associated Infections
4.6.3.9 Respiratory Syncytial Virus Poc
4.6.3.10 Infectious Disease Testing Market, By Respiratory Syncytial Virus (Rsv) Poc
4.6.3.11 Hpv Poc
4.6.3.12 Infectious Disease Testing Market, By Hpv Poc
4.6.3.13 Influenza/Flu Poc
4.6.3.14 Infectious Disease Testing Market, By Influenza/Flu Poc
4.6.3.15 Hcv Poc
4.6.3.16 Infectious Disease Testing Market, By Hcv Poc
4.6.3.17 Mrsa Poc
4.6.3.18 Infectious Disease Testing Market, By Mrsa Poc
4.6.3.19 Tb And Drug - Resistant Tb Poc
4.6.3.20 Infectious Disease Testing Market, By Tb And Drug - Resistant Tb Poc
4.6.3.21 Hsv Poc
4.6.3.22 Infectious Disease Testing Market, By Hsv Poc
4.6.3.23 Covid - 19
4.6.3.24 Infectious Disease Testing Market, By Covid - 19
4.6.3.25 Other Infectious Diseases
4.6.3.26 Infectious Disease Testing Market, By Other Infectious Diseases
4.7 Cardiac Markers
4.7.1 Cardiac Markers Market Estimates And Forecast, 2020 - 2032
4.7.2 Cardiac Markers Market, By End - Use
4.7.2.1 Cardiac Markers Market, By Hospital
4.7.2.2 Cardiac Markers Market, By Laboratories
4.7.2.3 Cardiac Markers Market, By Home Care
4.7.2.4 Cardiac Markers Market, By Clinic
4.7.2.5 Cardiac Markers Market, By Physician Office
4.7.2.6 Cardiac Markers Market, By Pharmacy & Retail Clinics
4.7.2.7 Cardiac Markers Market, By Non - Practice Clinics
4.7.2.8 Cardiac Markers Market, By Urgent Care Clinics
4.7.2.9 Cardiac Markers Market, By Others
4.7.2.10 Cardiac Markers Market, By Rural Health Clinic
4.7.2.11 Cardiac Markers Market, By Federally Qualified Health Clinic (Fqhc)
4.7.3 Cardiac Markers Market, By Disease
4.7.3.1 Acute Coronary Syndrome
4.7.3.2 Cardiac Markers Market, By Acute Coronary Syndrome
4.7.3.3 Myocardial Infarction
4.7.3.4 Cardiac Markers Market, By Myocardial Infarction
4.7.3.5 Congestive Heart Failure
4.7.3.6 Cardiac Markers Market, By Congestive Heart Failure
4.7.3.7 Others
4.7.3.8 Cardiac Markers Market, By Others
4.7.4 Cardiac Markers Market, By Marker
4.8 Thyroid Stimulating Hormone
4.8.1 Thyroid Stimulating Hormone Market Estimates And Forecast, 2020 - 2032
4.8.2 Thyroid Stimulating Hormone Market, By End - Use
4.8.2.1 Thyroid Stimulating Hormone Market, By Hospital
4.8.2.2 Thyroid Stimulating Hormone Market, By Laboratories
4.8.2.3 Thyroid Stimulating Hormone Market, By Home Care
4.8.2.4 Thyroid Stimulating Hormone Market, By Clinic
4.8.2.5 Thyroid Stimulating Hormone Market, By Physician Office
4.8.2.6 Thyroid Stimulating Hormone Market, By Pharmacy & Retail Clinics
4.8.2.7 Thyroid Stimulating Hormone Market, By Non - Practice Clinics
4.8.2.8 Thyroid Stimulating Hormone Market, By Urgent Care Clinics
4.8.2.9 Thyroid Stimulating Hormone Market, By Others
4.8.2.10 Thyroid Stimulating Hormone Market, By Rural Health Clinic
4.8.2.11 Thyroid Stimulating Hormone Market, By Federally Qualified Health Clinic (Fqhc)
4.8.3 Thyroid Stimulating Hormone Market, By Disease
4.8.3.1 Hyperthyroidism
4.8.3.2 Thyroid Stimulating Hormone Market, By Hyperthyroidism
4.8.3.3 Hypothyroidism
4.8.3.4 Thyroid Stimulating Hormone Market, By Hypothyroidism
4.9 Hematology
4.9.1 Hematology Market Estimates And Forecast, 2020 - 2032
4.9.2 Hematology Market, By End - Use
4.9.2.1 Hematology Market, By Hospital
4.9.2.2 Hematology Market, By Laboratories
4.9.2.3 Hematology Market, By Home Care
4.9.2.4 Hematology Market, By Clinic
4.9.2.5 Hematology Market, By Physician Office
4.9.2.6 Hematology Market, By Pharmacy & Retail Clinics
4.9.2.7 Hematology Market, By Non - Practice Clinics
4.9.2.8 Hematology Market, By Urgent Care Clinics
4.9.2.9 Hematology Market, By Others
4.9.2.10 Hematology Market, By Rural Health Clinic
4.9.2.11 Hematology Market, By Federally Qualified Health Clinic (Fqhc)
4.9.3 Hematology Market, By Disease
4.9.3.1 Anemia
4.9.3.2 Hematology Market, By Anemia
4.9.3.3 Leukemia
4.9.3.4 Hematology Market, By Leukemia
4.9.3.5 Others
4.9.3.6 Hematology Market, By Others
4.10 Primary Care Systems
4.10.1 Primary Care Systems Market Estimates And Forecast, 2020 - 2032
4.10.2 Primary Care Systems Market, By End - Use
4.10.2.1 Primary Care Systems Market, By Hospital
4.10.2.2 Primary Care Systems Market, By Laboratories
4.10.2.3 Primary Care Systems Market, By Home Care
4.10.2.4 Primary Care Systems Market, By Clinic
4.10.2.5 Primary Care Systems Market, By Physician Office
4.10.2.6 Primary Care Systems Market, By Pharmacy & Retail Clinics
4.10.2.7 Primary Care Systems Market, By Non - Practice Clinics
4.10.2.8 Primary Care Systems Market, By Urgent Care Clinics
4.10.2.9 Primary Care Systems Market, By Others
4.10.2.10 Primary Care Systems Market, By Rural Health Clinic
4.10.2.11 Primary Care Systems Market, By Federally Qualified Health Clinic (Fqhc)
4.11 Decentralized Clinical Chemistry
4.11.1 Decentralized Clinical Chemistry Market Estimates And Forecast, 2020 - 2032
4.11.2 Decentralized Clinical Chemistry Market, By End - Use
4.11.2.1 Decentralized Clinical Chemistry Market, By Hospital
4.11.2.2 Decentralized Clinical Chemistry Market, By Laboratories
4.11.2.3 Decentralized Clinical Chemistry Market, By Home Care
4.11.2.4 Decentralized Clinical Chemistry Market, By Clinic
4.11.2.5 Decentralized Clinical Chemistry Market, By Physician Office
4.11.2.6 Decentralized Clinical Chemistry Market, By Pharmacy & Retail Clinics
4.11.2.7 Decentralized Clinical Chemistry Market, By Non - Practice Clinics
4.11.2.8 Decentralized Clinical Chemistry Market, By Urgent Care Clinics
4.11.2.9 Decentralized Clinical Chemistry Market, By Others
4.11.2.10 Decentralized Clinical Chemistry Market, By Rural Health Clinic
4.11.2.11 Decentralized Clinical Chemistry Market, By Federally Qualified Health Clinic (Fqhc)
4.12 Feces
4.12.1 Feces Point - Of - Care (Poc) Diagnostics Market Estimates And Forecast, 2020 - 2032
4.12.2 Feces Market, By End - Use
4.12.2.1 Feces Market, By Hospital
4.12.2.2 Feces Market, By Laboratories
4.12.2.3 Feces Market, By Home Care
4.12.2.4 Feces Market, By Clinic
4.12.2.5 Feces Market, By Physician Office
4.12.2.6 Feces Market, By Pharmacy & Retail Clinics
4.12.2.7 Feces Market, By Non - Practice Clinics
4.12.2.8 Feces Market, By Urgent Care Clinics
4.12.2.9 Feces Market, By Others
4.12.2.10 Feces Market, By Rural Health Clinic
4.12.2.11 Feces Market, By Federally Qualified Health Clinic (Fqhc)
4.12.3 Feces Market, By Disease
4.12.3.1 Colorectal Cancer
4.12.3.2 Feces Market, By Colorectal Cancer
4.12.3.3 Gi Disorders
4.12.3.4 Feces Market, By Gi Disorders
4.12.3.5 Others
4.12.3.6 Feces Market, By Others
4.13 Lipid Testing
4.13.1 Lipid Market Estimates And Forecast, 2020 - 2032
4.13.2 Lipid Testing Market, By End - Use
4.13.2.1 Lipid Testing Market, By Hospital
4.13.2.2 Lipid Testing Market, By Laboratories
4.13.2.3 Lipid Testing Market, By Home Care
4.13.2.5 Lipid Testing Market, By Physician Office
4.13.2.6 Lipid Testing Market, By Pharmacy & Retail Clinics
4.13.2.7 Lipid Testing Market, By Non - Practice Clinics
4.13.2.8 Lipid Testing Market, By Urgent Care Clinics
4.13.2.9 Lipid Testing Market, By Others
4.13.2.9.1 Lipid Testing Market, By Rural Health Clinic
4.13.2.9.2 Lipid Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.13.3 Lipid Testing Market, By Disease
4.13.3.1 Hyperlipidemia
4.13.3.1.1 Lipid Testing Market, By Hyperlipidemia
4.13.3.2 Cardiovascular Diseases
4.13.3.2.1 Lipid Testing Market, By Cardiovascular Diseases
4.13.3.3 Others
4.13.3.3.1 Lipid Testing Market, By Others
4.14 Cancer Marker
4.14.1.1 Cancer Marker Market Estimates And Forecast, 2020 - 2032
4.14.2 Cancer Marker Market, By End - Use
4.14.2.1 Cancer Marker Market, By Hospital
4.14.2.2 Cancer Marker Market, By Laboratories
4.14.2.3 Cancer Marker Market, By Home Care
4.14.2.4 Cancer Marker Market, By Clinic
4.14.2.5 Cancer Marker Market, By Physician Office
4.14.2.6 Cancer Marker Market, By Pharmacy & Retail Clinics
4.14.2.7 Cancer Marker Market, By Non - Practice Clinics
4.14.2.8 Cancer Marker Market, By Urgent Care Clinics
4.14.2.9 Cancer Marker Market, By Others
4.14.2.10 Cancer Marker Market, By Rural Health Clinic
4.14.2.11 Cancer Marker Market, By Federally Qualified Health Clinic (Fqhc)
4.14.3 Cancer Marker Market, By Disease
4.14.3.1 Breast Cancer
4.14.3.2 Cancer Marker Market, By Breast Cancer
4.14.3.3 Prostate Cancer
4.14.3.4 Cancer Marker Market, By Prostate Cancer
4.14.3.5 Colorectal Cancer
4.14.3.6 Cancer Marker Market, By Colorectal Cancer
4.14.3.7 Kidney Cancer
4.14.3.8 Cancer Marker Market, By Kidney Cancer
4.14.3.9 Lung Cancer
4.14.3.10 Cancer Marker Market, By Lung Cancer
4.14.3.11 Bladder Cancer
4.14.3.12 Cancer Marker Market, By Bladder Cancer
4.14.3.13 Other Cancer
4.14.3.14 Cancer Marker Market, By Other
4.14.4 Cancer Marker Market, By Marker
4.14.5 Blood Gas/Electrolytes
4.14.5.1 Blood Gas/Electrolytes Market Estimates And Forecast, 2020 - 2032
4.14.6 Blood Gas/Electrolytes Market, By End - Use
4.14.6.1 Blood Gas/Electrolytes Market, By Hospital
4.14.6.2 Blood Gas/Electrolytes Market, By Laboratories
4.14.6.3 Blood Gas/Electrolytes Market, By Home Care
4.14.6.4 Blood Gas/Electrolytes Market, By Clinic
4.14.6.5 Blood Gas/Electrolytes Market, By Physician Office
4.14.6.6 Blood Gas/Electrolytes Market, By Pharmacy & Retail Clinics
4.14.6.7 Blood Gas/Electrolytes Market, By Non - Practice Clinics
4.14.6.8 Blood Gas/Electrolytes Market, By Urgent Care Clinics
4.14.6.9 Blood Gas/Electrolytes Market, By Others
4.14.6.10 Blood Gas/Electrolytes Market, By Rural Health Clinic
4.14.6.11 Blood Gas/Electrolytes Market, By Federally Qualified Health Clinic (Fqhc)
4.14.7 Ambulatory Chemistry
4.14.7.1 Ambulatory Chemistry Market Estimates And Forecast, 2020 - 2032
4.14.8 Ambulatory Chemistry Market, By End - Use
4.14.8.1 Ambulatory Chemistry Market, By Hospital
4.14.8.2 Ambulatory Chemistry Market, By Laboratories
4.14.8.3 Ambulatory Chemistry Market, By Home Care
4.14.8.4 Ambulatory Chemistry Market, By Clinic
4.14.8.5 Ambulatory Chemistry Market, By Physician Office
4.14.8.6 Ambulatory Chemistry Market, By Pharmacy & Retail Clinics
4.14.8.7 Ambulatory Chemistry Market, By Non - Practice Clinics
4.14.8.8 Ambulatory Chemistry Market, By Urgent Care Clinics
4.14.8.9 Ambulatory Chemistry Market, By Others
4.14.8.10 Ambulatory Chemistry Market, By Rural Health Clinic
4.14.8.11 Ambulatory Chemistry Market, By Federally Qualified Health Clinic (Fqhc)
4.14.9 Drug Abuse Testing
4.14.9.1 Drug Abuse Testing Market Estimates And Forecast, 2020 - 2032
4.14.10 Drug Of Abuse (Doa) Testing Market, By End - Use
4.14.10.1 Drug Of Abuse (Doa) Testing Market, By Hospital
4.14.10.2 Drug Of Abuse (Doa) Testing Market, By Laboratories
4.14.10.3 Drug Of Abuse (Doa) Testing Market, By Home Care
4.14.10.4 Drug Of Abuse (Doa) Testing Market, By Clinic
4.14.10.5 Drug Of Abuse (Doa) Testing Market, By Physician Office
4.14.10.6 Drug Of Abuse (Doa) Testing Market, By Pharmacy & Retail Clinics
4.14.10.7 Drug Of Abuse (Doa) Testing Market, By Non - Practice Clinics
4.14.10.8 Drug Of Abuse (Doa) Testing Market, By Urgent Care Clinics
4.14.10.9 Drug Of Abuse (Doa) Testing Market, By Others
4.14.10.10 Drug Of Abuse (Doa) Testing Market, By Rural Health Clinic
4.14.10.11 Drug Of Abuse (Doa) Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.14.11 Urinalysis
4.14.11.1 Urinalysis Market Estimates And Forecast, 2020 - 2032
4.14.12 Urinalysis/Nephrology Market, By End - Use
4.14.12.1 Urinalysis/Nephrology Market, By Hospital
4.14.12.2 Urinalysis/Nephrology Market, By Laboratories
4.14.12.3 Urinalysis/Nephrology Market, By Home Care
4.14.12.4 Urinalysis/Nephrology Market, By Clinic
4.14.12.5 Urinalysis/Nephrology Market, By Physician Office
4.14.12.6 Urinalysis/Nephrology Market, By Pharmacy & Retail Clinics
4.14.12.7 Urinalysis/Nephrology Market, By Non - Practice Clinics
4.14.12.8 Urinalysis/Nephrology Market, By Urgent Care Clinics
4.14.12.9 Urinalysis/Nephrology Market, By Others
4.14.12.10 Urinalysis/Nephrology Market, By Rural Health Clinic
4.14.12.11 Urinalysis/Nephrology Market, By Federally Qualified Health Clinic (Fqhc)
4.14.13 Urinalysis/Nephrology Market, By Disease
4.14.13.1 Uti
4.14.13.2 Urinalysis/Nephrology Market, By Uti
4.14.13.3 Kidney Disease
4.14.13.4 Urinalysis/Nephrology Market, By Kidney Disease
4.14.13.5 Diabetes
4.14.13.6 Urinalysis/Nephrology Market, By Diabetes
4.14.13.7 Others
4.14.13.8 Urinalysis/Nephrology Market, By Others
Chapter 6 End - Use Business Analysis
6.1 North America Point - Of - Care Diagnostics Market: End - Use Movement Analysis
6.1.1 Clinics
6.1.1.1 Clinics Market Estimates And Forecast, 2020 - 2032
6.1.1.2 Pharmacy & Retail Clinics
6.1.1.2.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2020 - 2032
6.1.1.3 Physician Office
6.1.1.3.1 Physician Office Market Estimates And Forecast, 2020 - 2032
6.1.1.4 Urgent Care Clinics
6.1.1.4.1 Urgent Care Clinics Market Estimates And Forecast, 2020 - 2032
6.1.1.5 Non - Practice Clinics
6.1.1.5.1 Non - Practice Clinics Market Estimates And Forecast, 2020 - 2032
6.1.1.6 Others
6.1.1.6.1 Others Market Estimates And Forecast, 2020 - 2032
6.1.1.6.2 Rural Health Clinic
6.1.1.6.2.1 Rural Health Clinic Market Estimates And Forecast, 2020 - 2032
6.1.1.6.3 Federally Qualified Health Clinic (Fqhc)
6.1.1.6.3.1 Federally Qualified Health Clinic Market Estimates And Forecast, 2020 - 2032
6.1.2 Hospitals
6.1.2.1 Hospitals Market Estimates And Forecast, 2020 - 2032
6.1.3 Home Care
6.1.3.1 Home Care Market Estimates And Forecast, 2020 - 2032
6.1.3.2 Self - Testing
6.1.3.2.1 Self - Testing Market For Self - Testing, 2020 - 2032
6.1.3.3 Self - Collection
6.1.3.4 Self - Collection Market For Self - Collection Facilities, 2020 - 2032
6.1.4 Laboratories
6.1.4.1 Laboratories Market For Laboratory, 2020 - 2032
Chapter 7 Type Business Analysis
7.1 North America Point - Of - Care Diagnostics Market: Type Movement Analysis
7.1.1 Ldt
7.1.1.1 Ldt Market Estimates And Forecast, 2020 - 2032
7.1.2 Other Poc
7.1.2.1 Other Poc Market Estimates And Forecast, 2020 - 2032
Chapter 8 North America Poc Diagnostics Market: Regional Estimates And Trend Analysis, By Product, Type, & End - Use, And Location
8.1 North America
8.1.1 Swot Analysis:
8.1.1.1 North America Poc Market Estimates And Forecasts, 2020 - 2032
8.1.2 U.S.
8.1.2.1 Key Country Dynamics
8.1.2.2 Research And Development Statistics
8.1.2.3 Competitive Scenario
8.1.2.4 Regulatory Framework
8.1.2.5 Reimbursement Scenario
8.1.2.6 U.S. Poc Market Estimates And Forecasts, 2020 - 2032
8.1.3 Canada
8.1.3.1 Key Country Dynamics
8.1.3.2 Target Disease Prevalence
8.1.3.3 Competitive Scenario
8.1.3.4 Regulatory Framework
8.1.3.5 Reimbursement Scenario
8.1.3.6 Canada Poc Market Estimates And Forecasts, 2020 - 2032
Chapter 9 Competitive Landscape
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Vendor Landscape
9.2.1 Key Distributors Marketing Channels
9.2.2 Market Leaders, Emerging Companies, And Key Innovators
9.2.2.1 Abbott Diagnostics
9.2.2.2 Abbott Diagnostics: Marketing Channels & Distribution Network For Poc
9.2.2.3 Alere, Inc.
9.2.2.4 Alere, Inc.: Marketing Channels & Distribution Network For Poc
9.2.2.5 Roche Diagnostics
9.2.2.6 Roche Diagnostics: Marketing Channels & Distribution Network For Poc
9.2.2.7 Siemens Healthineers
9.2.2.8 Siemens Healthineers: Marketing Channels & Distribution Network For Poc
9.2.2.9 Danaher Corporation
9.2.2.10 Danaher Corporation: Marketing Channels & Distribution Network For Poc
9.2.2.11 Instrumentation Laboratory Spa
9.2.2.12 Instrumentation Laboratory Spa.: Marketing Channels & Distribution Network For Poc
9.2.2.13 Becton Dickinson
9.2.2.14 Becton Dickinson.: Marketing Channels & Distribution Network For Poc
9.2.3 Key Customers
9.3 Company Market Positioning Analysis, 2021
9.3.1 Glucose Monitoring
9.3.2 Cardiac Markers
9.3.3 Hematology
9.3.4 Coagulation
9.3.5 Fertility Testing
9.3.6 Infectious Diseases
9.3.7 Decentralized Clinical Chemistry
9.3.8 Oncology Markers
9.3.9 Blood Gas Testing
9.3.10 Ambulatory Chemistry
9.3.11 Drugs Of Abuse
9.3.12 Urinalysis
9.4 Key Parameters
9.4.1 Company Size
9.4.2 Geographic Presence And Distribution Network
9.4.3 Product Portfolio
9.4.4 Collaborations
9.5 Competitive Dashboard Analysis
9.6 Market Differentiators
9.6.1 Application Trends
9.6.2 Technology Trends
9.6.3 Test Location Trends
9.6.4 End - Use Trends
9.6.5 Regional Trends
9.7 Private Companies
9.7.1 New Entrants/Emerging Players
9.8 Product Market Share, 2021
9.9 Participant’s Overview
9.10 Financial Performance
9.11 Participant Categorization
9.11.1 Market Leaders
9.11.1.1 North America Poc Market Share Analysis, 2022
9.11.2 Strategy Mapping
9.11.2.1 Expansion
9.11.2.2 Acquisition
9.11.2.3 Partnership
9.11.2.4 Product/Service Launch
9.11.2.5 Others
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers